Published by Iain Gilbert on 30th June 2022
(Sharecast News) - Pharmaceutical giant AstraZeneca has received positive results from a planned interim analysis of the AEGEAN Phase III trial on its resectable non-small cell lung cancer drug.
URL: http://www.digitallook.com/dl/news/story/32787055/...